{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T17:21:43Z","timestamp":1769880103263,"version":"3.49.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>This study aimed to investigate the bacterial characteristics of pneumococcal isolates obtained from a tertiary care hospital in Japan. We analyzed the antimicrobial susceptibility, possession of macrolide resistance genes, pneumococcal serogroup\/serotype, and sequence type (ST) of pneumococcal isolates from patients aged 15 years or older between 2011 and 2020 at Nagasaki University Hospital. Of the 73 isolates analyzed, 86.3% showed resistance to macrolides, and 28.8%, 46.6%, and 11.0% harbored <jats:italic>mefA<\/jats:italic>, <jats:italic>ermB<\/jats:italic>, and both, respectively. Of the isolates possessing <jats:italic>ermB<\/jats:italic>, 97.6% showed high levels of macrolide resistance [minimal inhibitory concentration (MIC) range, &amp;gt; 16 \u00b5g\/mL]. Solithromycin (MIC range, 0.03\u20130.25 \u00b5g\/mL), regardless of the presence of macrolide resistance genes, and lascufloxacin (MIC range, 0.06\u20130.5 \u00b5g\/mL) showed potent <jats:italic>in vitro<\/jats:italic> activity against pneumococci. Serotype 19A was the most prevalent (six isolates), followed by serotypes 10A, 15A, and 15B\/C (five isolates each). Four serotypes (11A, 19A, 22F, and 23B) and five STs (36, 99, 433, 558, and 3111) were significantly correlated with the presence of macrolide resistance genes. All four isolates with serotype 11A\/ST99 and three isolates with serotype 19A\/ST3111 harbored both <jats:italic>mefA<\/jats:italic> and <jats:italic>ermB<\/jats:italic>. No macrolide resistance genes were detected in either of the two isolates with serotype 22F\/ST433, while all ten isolates with serogroup 15 (serotypes 15A and 15B\/C, five isolates each) possessed <jats:italic>ermB<\/jats:italic> alone. Our study revealed the bacterial characteristics of the pneumococcal isolates obtained from our hospital. <jats:italic>In vitro<\/jats:italic> activity of solithromycin and lascufloxacin against these isolates was confirmed.<\/jats:p>","DOI":"10.3389\/fcimb.2024.1391879","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T09:21:25Z","timestamp":1721640085000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular and phenotypic characterization of Streptococcus pneumoniae isolates in a Japanese tertiary care hospital"],"prefix":"10.3389","volume":"14","author":[{"given":"Takumi","family":"Nakao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Kosai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Akamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fujiko","family":"Mitsumoto-Kaseida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroo","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Izumikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsunori","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.diagmicrobio.2008.10.002","article-title":"Distribution of capsular serotypes and macrolide resistance mechanisms among macrolide-resistant Streptococcus pneumoniae isolates in Korea","volume":"63","author":"Bae","year":"2009","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1128\/AAC.46.3.680-688.2002","article-title":"Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995","volume":"46","author":"Brueggemann","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1128\/JCM.01919-08","article-title":"PCR-based quantitation and clonal diversity of the current prevalent invasive serogroup 6 pneumococcal serotype, 6C, in the United States in 1999 and 2006 to 2007","volume":"47","author":"Carvalho Mda","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3201\/eid2007.131485","article-title":"Changes in capsule and drug resistance of Pneumococci after introduction of PCV7, Japan 2010-2013","volume":"20","author":"Chiba","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1164\/rccm.201502-0212OC","article-title":"The effect of macrolide resistance on the presentation and outcome of patients hospitalized for Streptococcus pneumoniae pneumonia","volume":"191","author":"Cilloniz","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.micinf.2012.01.012","article-title":"Streptococcus pneumoniae: the evolution of antimicrobial resistance to beta-lactams, fluoroquinolones and macrolides","volume":"14","author":"Cornick","year":"2012","journal-title":"Microbes Infect."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1128\/JCM.02243-09","article-title":"Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes","volume":"48","author":"da Gloria Carvalho","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jiac.2017.03.014","article-title":"Impact of the pneumococcal conjugate vaccine on serotype distribution of adult non-invasive Streptococcus pneumoniae isolates in Tokai region, Japan 2008-2016","volume":"23","author":"Furuya","year":"2017","journal-title":"J. Infect. Chemother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e0039523","DOI":"10.1128\/aac.00395-23","article-title":"New resistance mutations linked to decreased susceptibility to solithromycin in Streptococcus pneumoniae revealed by chemogenomic screens","volume":"67","author":"Gingras","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3201\/eid2801.210734","article-title":"Serotype replacement after introduction of 10-valent and 13-valent pneumococcal conjugate vaccines in 10 countries, Europe","volume":"28","author":"Hanquet","year":"2022","journal-title":"Emerg. Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijantimicag.2017.01.035","article-title":"Surveillance of the activity of solithromycin (CEM-101) against bacteria from respiratory tract infections","volume":"50","author":"Hawser","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.jiph.2020.04.012","article-title":"High prevalence of antimicrobial resistance in non-vaccine serotypes of non-invasive\/colonization isolates of Streptococcus pneumoniae: A cross-sectional study eight years after the licensure of conjugate vaccine in Japan","volume":"13","author":"Kawaguchiya","year":"2020","journal-title":"J. Infect. Public. Health"},{"key":"B14","doi-asserted-by":"publisher","first-page":"6571","DOI":"10.1038\/s41598-023-33265-1","article-title":"Clinical and microbiological characteristics of bloodstream infection caused by Klebsiella pneumoniae harboring rmpA in Japanese adults","volume":"13","author":"Kikuchi","year":"2023","journal-title":"Sci. Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e00120","DOI":"10.1128\/AAC.00120-17","article-title":"In vitro activities and spectrum of the novel fluoroquinolone lascufloxacin (KRP-AM1977)","volume":"61","author":"Kishii","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.2169\/internalmedicine.53.2499","article-title":"Importance of functional assessment in the management of community-acquired and healthcare-associated pneumonia","volume":"53","author":"Kosai","year":"2014","journal-title":"Intern. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"127221","DOI":"10.1016\/j.micres.2022.127221","article-title":"Epidemiological characteristics and antibiotic resistance mechanisms of Streptococcus pneumoniae: An updated review","volume":"266","author":"Li","year":"2023","journal-title":"Microbiol. Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1128\/JCM.43.5.2125-2132.2005","article-title":"Molecular epidemiology of macrolide-resistant isolates of Streptococcus pneumoniae collected from blood and respiratory specimens in Norway","volume":"43","author":"Littauer","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1128\/AAC.00860-10","article-title":"Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis","volume":"54","author":"Llano-Sotelo","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1086\/324527","article-title":"Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia","volume":"34","author":"Lynch","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1128\/AAC.01123-09","article-title":"In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms","volume":"54","author":"McGhee","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1164\/arrd.1963.88.4.473","article-title":"A study of techniques for the examination of sputum in a field survey of chronic bronchitis","volume":"88","author":"Miller","year":"1963","journal-title":"Am. Rev. Respir. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e01971","DOI":"10.1128\/AAC.01971-17","article-title":"In vitro activity of lascufloxacin against Streptococcus pneumoniae with mutations in the quinolone resistance-determining regions","volume":"62","author":"Murata","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B24","article-title":"Shinshuseihaienkyukinkansenshobyogentaikenshutsumanyuaru. (in Japanese)","year":"2021"},{"key":"B25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jiac.2014.03.010","article-title":"Impact of the pneumococcal conjugate vaccine on serotype distribution and susceptibility trends of pediatric non-invasive Streptococcus pneumoniae isolates in Tokai, Japan over a 5-year period","volume":"20","author":"Okade","year":"2014","journal-title":"J. Infect. Chemother."},{"key":"B26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1128\/JCM.44.1.124-131.2006","article-title":"Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates","volume":"44","author":"Pai","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1128\/AAC.40.10.2321","article-title":"Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae","volume":"40","author":"Pan","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1128\/JCM.00704-09","article-title":"Rarely occurring 19A-like cps locus from a serotype 19F pneumococcal isolate indicates continued need of serology-based quality control for PCR-based serotype determinations","volume":"47","author":"Pimenta","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1089\/mdr.2016.0021","article-title":"In vitro resistance development to nemonoxacin in Streptococcus pneumoniae: A unique profile for a novel nonfluorinated quinolone","volume":"22","author":"Roychoudhury","year":"2016","journal-title":"Microb. Drug Resist."},{"key":"B30","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1186\/s12879-014-0704-z","article-title":"Increase in the rate of azithromycin-resistant Streptococcus pneumoniae isolates carrying the erm(B) and mef(A) genes in Taiwan 2006-2010","volume":"14","author":"Safari","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2016.00098","article-title":"Macrolide resistance in Streptococcus pneumoniae","volume":"6","author":"Schroeder","year":"2016","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B32","volume-title":"The Japanese Respiratory Society Guidelines for the Management of Pneumonia in Adults","year":"2017"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1128\/AAC.45.12.3517-3523.2001","article-title":"Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae","volume":"45","author":"Weigel","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/jac\/dkm273","article-title":"Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004)","volume":"60","author":"Wierzbowski","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1128\/AAC.01268-09","article-title":"Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates","volume":"54","author":"Xu","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jiac.2018.11.012","article-title":"Molecular and epidemiological analysis of IMP-1 metallo-\u03b2-lactamase-producing Klebsiella pneumoniae in a tertiary care hospital in Japan","volume":"25","author":"Yamakawa","year":"2019","journal-title":"J. Infect. Chemother."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1391879\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T09:22:06Z","timestamp":1721640126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1391879\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,22]]},"references-count":36,"alternative-id":["10.3389\/fcimb.2024.1391879"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2024.1391879","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,22]]},"article-number":"1391879"}}